secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001159036-25-000068
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme elects James Lang to Board of Directors, term through 2027 annual meeting
--------------------------------------------------------------------------------

- James Lang elected to Halozyme's Board on December 4, 2025.
- Mr. Lang's term expires at the 2027 annual meeting of stockholders.
- No Board committee assignments initially made.
- Compensation follows standard non-employee director program as described in the 2025 proxy.
- No related party transactions or arrangements exist with Mr. Lang.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000068/0001159036-25-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000068/halo-20251204.htm
  HTML page:      https://secwatch.observer/filing/0001159036-25-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer